B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 3 405 KRW 0.89% Market Closed
Market Cap: ₩209.9B

Wall St Price Targets

Price Targets Summary
BioPlus Co Ltd

Wall Street analysts forecast BioPlus Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BioPlus Co Ltd is 9 690 KRW with a low forecast of 9 595 KRW and a high forecast of 9 975 KRW.

Lowest Forecast
Price Target
9 595 KRW
182% Upside
Average Forecast
Price Target
9 690 KRW
185% Upside
Highest Forecast
Price Target
9 975 KRW
193% Upside
BioPlus Co Ltd Competitors:
Price Targets

Revenue
Forecast

32% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
32% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 2 years is 25%.

Gross Profit
Forecast

32% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
32% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 1 year is -39%.

Operating Income
Forecast

14% / Year
Past Growth
85% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
85% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 2 years is 85%.

Pre-Tax Income
Forecast

17% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
17% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 2 years is 74%.

Net Income
Forecast

18% / Year
Past Growth
60% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
18% / Year
Past Growth
60% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 2 years is 60%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BioPlus Co Ltd's stock price target?
Price Target
9 690 KRW

According to Wall Street analysts, the average 1-year price target for BioPlus Co Ltd is 9 690 KRW with a low forecast of 9 595 KRW and a high forecast of 9 975 KRW.

What is the Revenue forecast for BioPlus Co Ltd?
Projected CAGR
25%

Over the last 6 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 2 years is 25%.

What is the Gross Profit forecast for BioPlus Co Ltd?
Projected CAGR
-39%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 1 year is -39%.

What is the Operating Income forecast for BioPlus Co Ltd?
Projected CAGR
85%

Over the last 6 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 2 years is 85%.

What is the Pre-Tax Income forecast for BioPlus Co Ltd?
Projected CAGR
74%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 2 years is 74%.

What is the Net Income forecast for BioPlus Co Ltd?
Projected CAGR
60%

Over the last 6 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 2 years is 60%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett